Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep 1;25(5):627-631.
doi: 10.4103/aja2022119. Epub 2023 Mar 3.

Insufficiency of Mrpl40 disrupts testicular structure and semen parameters in a murine model

Affiliations

Insufficiency of Mrpl40 disrupts testicular structure and semen parameters in a murine model

Ying Liu et al. Asian J Androl. .

Abstract

Approximately 31% of patients with 22q11.2 deletion syndrome (22q11.2DS) have genitourinary system disorders and 6% of them have undescended testes. Haploinsufficiency of genes on chromosome 22q11.2 might contribute to the risk of 22q11.2DS. In this study, we used mice with single-allele deletion in mitochondrial ribosomal protein L40 ( Mrpl40 +/- ) as models to investigate the function of Mrpl40 in testes and spermatozoa development. The penetrance of cryptorchidism in Mrpl40 +/- mice was found to be higher than that in wild-type (WT) counterparts. Although the weight of testes was not significantly different between the WT and Mrpl40 +/- mice, the structure of seminiferous tubules and mitochondrial morphology was altered in the Mrpl40 +/- mice. Moreover, the concentration and motility of spermatozoa were significantly decreased in the Mrpl40 +/- mice. In addition, data-independent acquisition mass spectrometry indicated that the expression of genes associated with male infertility was altered in Mrpl40 +/- testes. Our study demonstrated the important role of Mrpl40 in testicular structure and spermatozoa motility and count. These findings suggest that Mrpl40 is potentially a novel therapeutic target for cryptorchidism and decreased motility and count of spermatozoa.

PubMed Disclaimer

Conflict of interest statement

All authors declare no competing interests.

Figures

Figure 1
Figure 1
Identification of genotypes and phenotypes of the Mrpl40+/− mouse model. (a) The strategy used to establish the Mrpl40+/− mouse model. (b) The genotype of the mice. The 390-bp band in Lanes 1 and 4 indicated Mrpl40+/−, and Lanes 2 and 3 without the 390-bp band indicated WT. The 325-bp band was the positive control. M: DL2000 DNA marker. (c) Bilateral and unilateral cryptorchidism investigated in the WT and Mrpl40+/− mice. The testes are outlined in yellow. (d) The IHC results of Mrpl40 in the testes. Scale bar = 50 μm. WT: wild type; Cas9: CRISPR-associated protein 9; sgRNA: single guide RNA; IHC: immunohistochemistry; Mrpl40: mitochondrial ribosomal protein L40.
Figure 2
Figure 2
Morphology of the testes. (a) The testes that were localized correctly in Mrpl40+/− mice appeared with normal morphology. (b) The Mrpl40+/− testes had a normal organ/body weight ratio. (c) The morphology of mitochondria in the WT and Mrpl40+/− testes. NS: not significant. The data were analyzed by Student’s t-test and were expressed as the mean ± s.e.m. WT: wild type; Mrpl40: mitochondrial ribosomal protein L40; s.e.m.: standard error of the mean.
Figure 3
Figure 3
HE staining results of the testes in (a) WT and (b) Mrpl40+/ mice. Asterisks indicate abnormal seminiferous tubules. Scale bars = 200 μm. HE: hematoxylin and eosin; WT: wild type; Mrpl40: mitochondrial ribosomal protein L40.
Figure 4
Figure 4
Analysis of the spermatozoa. (a) The morphology of the spermatozoa from WT and Mrpl40+/− mice was normal. Scale bars=10 μm. (b) The sperm concentration and (c) the percent of motile spermatozoa in the Mrpl40+/− mice was decreased. *P < 0.05. The data were analyzed by Student’s t-test and were expressed as the mean ± s.e.m. WT: wild type; Mrpl40: mitochondrial ribosomal protein L40; s.e.m.: standard error of the mean.

References

    1. McDonald-McGinn DM, Sullivan KE, Marino B, Philip N, Swillen A, et al. 22q11.2 deletion syndrome. Nat Rev Dis Primers. 2015;1:15071. - PMC - PubMed
    1. Wu HY, Rusnack SL, Bellah RD, Plachter N, McDonald-McGinn DM, et al. Genitourinary malformations in chromosome 22q11.2 deletion. J Urol. 2002;168:2564–5. - PubMed
    1. Haller M, Mo Q, Imamoto A, Lamb DJ. Murine model indicates 22q11.2 signaling adaptor CRKL is a dosage-sensitive regulator of genitourinary development. Proc Natl Acad Sci U S A. 2017;114:4981–6. - PMC - PubMed
    1. Van Batavia JP, Crowley TB, Burrows E, Zackai EH, Sanna-Cherchi S, et al. Anomalies of the genitourinary tract in children with 22q11.2 deletion syndrome. Am J Med Genet A. 2019;179:381–5. - PMC - PubMed
    1. Beliaev AM, Mundy I. Bilateral simultaneous testicular torsion presenting as a diagnostic dilemma. BMJ Case Rep. 2013;2013:bcr2013010137. - PMC - PubMed